Literature DB >> 11189818

Hepatitis C among drug users: déjà vu all over again?

D C Des Jarlais1, A Schuchat.   

Abstract

Mesh：

Year:  2001        PMID： 11189818      PMCID： PMC1446496          DOI： 10.2105/ajph.91.1.21

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  6 in total

1.  Prevalence and duration of hepatitis C among injection drug users in San Francisco, Calif.

Authors:  J Lorvick; A H Kral; K Seal; L Gee; B R Edlin
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

Review 2.  Natural history of hepatitis C.

Authors:  L B Seeff
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

Review 3.  Hepatitis C virus transmission dynamics in injection drug users.

Authors:  H Hagan
Journal:  Subst Use Misuse       Date:  1998-04       Impact factor: 2.164

4.  Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness.

Authors:  S D Rosenberg; L A Goodman; F C Osher; M S Swartz; S M Essock; M I Butterfield; N T Constantine; G L Wolford; M P Salyers
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

5.  Sharing of drug preparation equipment as a risk factor for hepatitis C.

Authors:  H Hagan; H Thiede; N S Weiss; S G Hopkins; J S Duchin; E R Alexander
Journal:  Am J Public Health       Date:  2001-01       Impact factor: 9.308

6.  The importance of preventing hepatitis C virus infection among injection drug users in the United States.

Authors:  M J Alter; L A Moyer
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998
  6 in total
  8 in total

1.  Risk factors for hepatitis C virus infection among homeless adults.

Authors:  Adeline M Nyamathi; Elizabeth L Dixon; Wendie Robbins; Cynthia Smith; Dorothy Wiley; Barbara Leake; Douglas Longshore; Lillian Gelberg
Journal:  J Gen Intern Med       Date:  2002-02       Impact factor: 5.128

Review 2.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

3.  Impact of a positive hepatitis C diagnosis on homeless injecting drug users: a qualitative study.

Authors:  Charlotte Ne Tompkins; Nat Mj Wright; Lesley Jones
Journal:  Br J Gen Pract       Date:  2005-04       Impact factor: 5.386

Review 4.  Overview of substance abuse and hepatitis C virus infection and co-infections in India.

Authors:  Debasish Basu
Journal:  J Neuroimmune Pharmacol       Date:  2010-06-19       Impact factor: 4.147

5.  Injection drug users and the provision of hepatitis C-related services in a nationwide sample of drug treatment programs.

Authors:  Zdravko P Vassilev; Shiela M Strauss; Janetta Astone; Don C Des Jarlais
Journal:  J Behav Health Serv Res       Date:  2004 Apr-Jun       Impact factor: 1.505

6.  Hepatitis C virus infection in San Francisco's HIV-infected urban poor.

Authors:  Christopher S Hall; Edwin D Charlebois; Judith A Hahn; Andrew R Moss; David R Bangsberg
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

7.  A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users.

Authors:  Nat M J Wright; Charlotte N E Tompkins
Journal:  Harm Reduct J       Date:  2006-09-06

8.  Quantifying hepatitis C transmission risk using a new weighted scoring system for the Blood-Borne Virus Transmission Risk Assessment Questionnaire (BBV-TRAQ): applications for community-based HCV surveillance, education and prevention.

Authors:  Mark A Stoové; Craig L Fry; Nicholas Lintzeris
Journal:  Harm Reduct J       Date:  2008-04-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.